Welcome to Johns Hopkins Berman Institute of Bioethics
 

To view this email as a web page, go here.


 


 

SCOPENews.png
March 13, 2009

Stem cells
 

·         Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats
Journal of Comparative Neurology

·         Stem cell scaffold for stroke treatment
Nature

·         Alternative iPS cell characterization criteria for in vitro applications
Cell Stem Cell

·         Broader implications of defining standards for the pluripotency of iPSCs
Cell Stem Cell

·         What a week for iPS! 
The Niche

·         Scientists create stem cells purged of carcinogens used in process
LA Times

·         PD patient-derived iPS cells free of viral reprogramming factors
Cell

·         Why hESCs make teratomas
Nature Reports: Stem Cells

·         Highly efficient neural conversion of human embryonic and induced pluripotent stem cells by dual inhibition of SMAD signaling
Nature Biotechnology

gavel copy

·         Remarks of President Barack Obama: Signing of Stem Cell Executive Order and Scientific Integrity Presidential Memorandum

·         Executive Order: Removing Barriers to Responsible Scientific Research Involving Human Stem Cells

·         Presidential Memorandum: Scientific Integrity

·         Zach Hall on Monday at the Whie House
California Stem Cell Report

·         Some states push back against SC research
Associated Press

·         Will the UK have to stem brain drain?
BBC

·         Stem cell focus part of new Harvard major
CBS

·         Stem cell decision worries some scientists
NY Times

·         ISSCR scientists elated for future of hESC research after Obama lifts funding ban
International Society for Stem Cell Research

·         Industry set for stem cell profits
Scientist

 

Ethics

·          Science vs. Ethics? 
Washington Post

·         The president politicizes stem-cell research
Wall Street Journal

·         Obama aims to shield science from politics
Washington Post

·         Finally, a coherent stem cell policy
MSNBC

·         Product regulation and the clinical translation of stem cell Research
Stem Cell Reviews and Reports

The Stem Cell Policy and Ethics (SCOPE) program is a collaborative effort of the Johns Hopkins Berman Institute of Bioethics and the  Johns Hopkins Institute for Cell Engineering. The SCOPE program is designed to address the increasing importance – in both the conduct of research and the development of clinical applications – of interactions between the fields of stem cell science, ethics, and public policy.  The goals of the group include facilitating the ability of the public to benefit from advances in cell engineering in morally responsible ways, anticipating moral and policy challenges in stem cell science and cell engineering and providing opportunity for careful and interdisciplinary analysis of these challenges that will be of assistance to both policy makers and the public. The SCOPE stem cell news roundup presents a weekly survey of the science, policy and ethics of stem cell research. Please note: if this email is not helpful to you or If you know anyone else who may be interested in receiving this email, contact us and we will adjust our mailing list.

 

Johns Hopkins Berman Institute of Bioethics | 201 North Charles, Suite 1701 

Baltimore, MD 21201 | Office: 410-625-7871

Contact us: ishan@jhu.edu, alanr@jhu.edu


 Archived editions of SCOPE News Round Up

  www.BioethicsInstitute.org/StemCells